Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A Milligan

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Chromatography|April 15, 1992
Determination of piroxicam and its major metabolites in the plasma, urine and bile of humans by high-performance liquid chromatographyP A Milligan
CPT: Pharmacometrics & Systems Pharmacology|July 10, 2013
The Role of Modeling and Simulation in Development and Registration of Medicinal Products: Output From the EFPIA/EMA Modeling and Simulation WorkshopE Manolis, S Rohou, R Hemmings, et al.
European Journal of Clinical Pharmacology|January 1, 1993
The consequences of H2 receptor antagonist--piroxicam coadministration in patients with joint disordersP A Milligan, P E McGill, C W Howden, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 6, 2013
PKPD Modeling of Predictors for Adverse Effects and Overall Survival in Sunitinib-Treated Patients With GISTE K Hansson, G Ma, M A Amantea, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 22, 2013
PKPD Modeling of VEGF, sVEGFR-2, sVEGFR-3, and sKIT as Predictors of Tumor Dynamics and Overall Survival Following Sunitinib Treatment in GISTE K Hansson, M A Amantea, P Westwood, et al.
Clinical Pharmacology and Therapeutics|May 25, 2007
Model-based drug developmentR L Lalonde, K G Kowalski, M M Hutmacher, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 13, 2016
Good Practices in Model-Informed Drug Discovery and Development: Practice, Application, and Documentation, S F Marshall, R Burghaus, et al.
Clinical Pharmacology and Therapeutics|April 17, 2013
Model-based drug development: a rational approach to efficiently accelerate drug developmentP A Milligan, M J Brown, B Marchant, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 31, 2015
Pharmacometrics Markup Language (PharmML): Opening New Perspectives for Model Exchange in Drug DevelopmentM J Swat, S Moodie, S M Wimalaratne, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Chromatography|April 15, 1992
Determination of piroxicam and its major metabolites in the plasma, urine and bile of humans by high-performance liquid chromatographyP A Milligan
CPT: Pharmacometrics & Systems Pharmacology|July 10, 2013
The Role of Modeling and Simulation in Development and Registration of Medicinal Products: Output From the EFPIA/EMA Modeling and Simulation WorkshopE Manolis, S Rohou, R Hemmings, et al.
European Journal of Clinical Pharmacology|January 1, 1993
The consequences of H2 receptor antagonist--piroxicam coadministration in patients with joint disordersP A Milligan, P E McGill, C W Howden, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 6, 2013
PKPD Modeling of Predictors for Adverse Effects and Overall Survival in Sunitinib-Treated Patients With GISTE K Hansson, G Ma, M A Amantea, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 22, 2013
PKPD Modeling of VEGF, sVEGFR-2, sVEGFR-3, and sKIT as Predictors of Tumor Dynamics and Overall Survival Following Sunitinib Treatment in GISTE K Hansson, M A Amantea, P Westwood, et al.
Clinical Pharmacology and Therapeutics|May 25, 2007
Model-based drug developmentR L Lalonde, K G Kowalski, M M Hutmacher, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 13, 2016
Good Practices in Model-Informed Drug Discovery and Development: Practice, Application, and Documentation, S F Marshall, R Burghaus, et al.
Clinical Pharmacology and Therapeutics|April 17, 2013
Model-based drug development: a rational approach to efficiently accelerate drug developmentP A Milligan, M J Brown, B Marchant, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 31, 2015
Pharmacometrics Markup Language (PharmML): Opening New Perspectives for Model Exchange in Drug DevelopmentM J Swat, S Moodie, S M Wimalaratne, et al.
Pageof 1